Similar Items: Pingueculitis in psoriasis patient on secukinumab – An unreported adverse event
- Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study
- Bullous Pemphigoid Possibly Induced by Deucravacitinib in a Patient with Psoriasis
- Immunosenescence in Older Patients with Psoriasis: Mechanistic Insights and Opportunities for Biologic Therapy
- Successful Treatment of Two Rare Pediatric Keratinization Disorders with Secukinumab: Epidermolytic Ichthyosis and PRP–GPP Overlap
- Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis
- Paraneoplastic Papuloerythroderma of Ofuji Masquerading as Worsening Psoriasis